Heart Failure POC and LOC Devices Market - 2025-2033

July 2025 | 59 pages | ID: H041572E1CD2EN
DataM Intelligence

Abstracts

Heart Failure POC and LOC Devices Market reached US$ 127.79 Million in 2024 and is expected to reach US$ 451.93 Million by 2033, growing with a CAGR of 15.20% during the forecast period 2026-2033.

The Heart Failure POC and LOC Devices Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled market intelligence. This insightful report meticulously explores the competitive landscape, profiling key players and their forward-thinking innovations in product development, pricing strategies, financial metrics, and global expansion initiatives. By uncovering the driving forces, market dynamics, and disruptive trends shaping the future, this research equips industry stakeholders with the actionable insights needed to make informed decisions in an increasingly dynamic and competitive environment.

A Heart Failure POC and LOC Devices Market is a data-driven software solution that collects, integrates, analyzes, and visualizes customer data across various touchpoints to generate actionable insights. These platforms help businesses understand customer behaviors, preferences, and purchasing patterns in real time, enabling personalized marketing, enhanced customer engagement, and data-driven decision-making.

By Test Type

• Proteomic Testing*
• Metabolomic Testing
• Genomic Testing

By Technology

• Microfluidics*
• Array-Based Systems
• Others

By Product Type

• Wearable Devices*
• Implantable Devices
• Handheld Devices

By End-User

• Hospitals*
• Specialty Clinics
• Homecare Settings
• Assisted Living Healthcare Facilities
• Laboratories
• Others

Regional Analysis for Heart Failure POC and LOC Devices Market:

• North America (U.S., Canada, Mexico)
• Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
• Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
• South America (Colombia, Brazil, Argentina, Rest of South America)
• Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

This Report Covers:

• Go-to-market Strategy.
• Neutral perspective on the market performance.
• Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.
• Customized regional/country reports as per request and country level analysis.
• Potential & niche segments and regions exhibiting promising growth covered.
• Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Research Process:

Both primary and secondary data sources have been used in the global Heart Failure POC and LOC Devices Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Contents

1. MARKET INTRODUCTION AND SCOPE

1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope

2. EXECUTIVE INSIGHTS AND KEY TAKEAWAYS

3. MARKET HIGHLIGHTS AND STRATEGIC TAKEAWAYS

3.1. Key Trends and Future Projections
3.2. Snippet by Test Type
3.3. Snippet by Technology
3.4. Snippet by Product Type
3.5. Snippet by End-User
3.6. Snippet by Region

4. DYNAMICS

4.1. Impacting Factors
  4.1.1. Drivers
    4.1.1.1. Rising Technological Advancements
    4.1.1.2. Rising Prevalence of Heart Failure
  4.1.2. Restraints
    4.1.2.1. High Cost of Advanced Devices and Limited Reimbursement
    4.1.2.2. Data Security and Interoperability Concerns
  4.1.3. Opportunity
    4.1.3.1. Integration of AI and Predictive Analytics in POC Devices
    4.1.3.2. Miniaturization and Battery-Free Operation
  4.1.4. Impact Analysis

5. STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK

5.1. Market Leaders and Pioneers
  5.1.1. Emerging Pioneers and Prominent Players
  5.1.2. Established Leaders with the Largest Marketing Brand
  5.1.3. Market Leaders with Established Products
5.2. Latest Developments and Breakthroughs
5.3. Regulatory and Reimbursement Landscape
  5.3.1. North America
  5.3.2. Europe
  5.3.3. Asia Pacific
  5.3.4. South America
  5.3.5. Middle East & Africa
5.4. Porter’s Five Forces Analysis
5.5. Supply Chain Analysis
5.6. Patent Analysis
5.7. SWOT Analysis
5.8. Unmet Needs and Gaps
5.9. Recommended Strategies for Market Entry and Expansion
5.10. Pricing Analysis and Price Dynamics

6. HEART FAILURE POC AND LOC DEVICES MARKET, BY TEST TYPE

6.1. Introduction
  6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
  6.1.2. Market Attractiveness Index, By Test Type
6.2. Proteomic Testing*
  6.2.1. Introduction
  6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Metabolomic Testing
6.4. Genomic Testing

7. HEART FAILURE POC AND LOC DEVICES MARKET, BY TECHNOLOGY

7.1. Introduction
  7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  7.1.2. Market Attractiveness Index, By Technology
7.2. Microfluidics*
  7.2.1. Introduction
  7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Array-Based Systems
7.4. Others

8. HEART FAILURE POC AND LOC DEVICES MARKET, BY PRODUCT TYPE

8.1. Introduction
  8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  8.1.2. Market Attractiveness Index, By Product Type
8.2. Wearable Devices*
  8.2.1. Introduction
  8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Implantable Devices
8.4. Handheld Devices

9. HEART FAILURE POC AND LOC DEVICES MARKET, BY END-USER

9.1. Introduction
  9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  9.1.2. Market Attractiveness Index, By End-User
9.2. Hospitals*
  9.2.1. Introduction
  9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Specialty Clinics
9.4. Homecare Settings
9.5. Assisted Living Healthcare Facilities
9.6. Laboratories
9.7. Others

10. HEART FAILURE POC AND LOC DEVICES MARKET, BY REGIONAL MARKET ANALYSIS AND GROWTH OPPORTUNITIES

10.1. Introduction
  10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    10.1.1.1. Market Attractiveness Index, By Region
10.2. North America
  10.2.1. Introduction
  10.2.2. Key Region-Specific Dynamics
  10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
  10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    10.2.7.1. U.S.
    10.2.7.2. Canada
    10.2.7.3. Mexico
10.3. Europe
  10.3.1. Introduction
  10.3.2. Key Region-Specific Dynamics
  10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
  10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    10.3.7.1. Germany
    10.3.7.2. UK
    10.3.7.3. France
    10.3.7.4. Spain
    10.3.7.5. Italy
    10.3.7.6. Rest of Europe
10.4. Asia-Pacific
  10.4.1. Introduction
  10.4.2. Key Region-Specific Dynamics
  10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
  10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    10.4.7.1. China
    10.4.7.2. India
    10.4.7.3. Japan
    10.4.7.4. South Korea
    10.4.7.5. Rest of Asia-Pacific
10.5. South America
  10.5.1. Introduction
  10.5.2. Key Region-Specific Dynamics
  10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
  10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    10.5.7.1. Brazil
    10.5.7.2. Argentina
    10.5.7.3. Rest of South America
10.6. Middle East and Africa
  10.6.1. Introduction
  10.6.2. Key Region-Specific Dynamics
  10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
  10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. COMPETITIVE LANDSCAPE AND MARKET POSITIONING

12. COMPETITIVE OVERVIEW AND KEY MARKET PLAYERS

12.1. Market Share Analysis and Positioning Matrix
12.2. Strategic Partnerships, Mergers & Acquisitions
12.3. Key Developments in Product Portfolios and Innovations
12.4. Company Benchmarking

13. COMPANY PROFILES

13.1. Abbott*
  13.1.1. Company Overview
  13.1.2. Product Portfolio
    13.1.2.1. Product Description
    13.1.2.2. Product Key Performance Indicators (KPIs)
  13.1.3. Financial Overview
    13.1.3.1. Company Revenue
    13.1.3.2. Geographical Revenue Shares
    13.1.3.3. Revenue Forecasts
  13.1.4. Key Developments
    13.1.4.1. Mergers & Acquisitions
    13.1.4.2. Key Product Development Activities
    13.1.4.3. Regulatory Approvals, etc.
    13.1.4.4. SWOT Analysis
13.2. F. Hoffmann-La Roche Ltd
13.3. Siemens Healthineers
13.4. QuidelOrtho Corporation
13.5. Jant Pharmacal Corporation
13.6. Trinity Biotech
13.7. bioM?rieux
13.8. Beckman Coulter, Inc. ( LIST NOT EXHAUSTIVE )

14. ASSUMPTIONS AND RESEARCH METHODOLOGY

14.1. Data Collection Methods
14.2. Data Triangulation
14.3. Forecasting Techniques
14.4. Data Verification and Validation

15. APPENDIX

15.1. About Us and Services
15.2. Contact Us
Suggestions for Related Report
• Congestive Heart Failure (CHF) Treatment Devices Market (https://www.datamintelligence.com/research-report/congestive-heart-failure-treatment-devices-market)
• Heart Attack Diagnostics Market (https://www.datamintelligence.com/research-report/heart-attack-diagnostics-market)
For more medical device-related reports, please click here (https://www.datamintelligence.com/industry-verticals/medical-devices)